Bruce E. Eaton
Director/Board Member bei Colorado BioScience Association
Vermögen: 554 949 $ am 31.03.2024
Profil
Bruce E.
Eaton founded i2 Pharmaceuticals, Inc. in 2015, where he worked as Chief Executive Officer from 2015 to 2018.
Dr. Eaton also currently works at Colorado BioScience Association, as Director and North Carolina State University, as Professor from 2000.
Dr. Eaton also formerly worked at NeXstar Pharmaceuticals, Inc., as Vice President-Chemistry from 1994 to 1999, Washington State University, as Professor from 1989 to 2000, SomaLogic Operating Co., Inc., as Chief Operating Officer from 2011 to 2012, Invenux, Inc., as President from 2000 to 2002, and Editas Medicine, Inc., as Executive Vice President from 2024.
Dr. Eaton received his doctorate degree in 1988 from the University of California, Berkeley, undergraduate degree in 1980 from the University of Oregon, and graduate degree in 1981 from the University of Oregon.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0,09% | 05.12.2023 | 74 791 ( 0,09% ) | 554 949 $ | 31.03.2024 |
Aktive Positionen von Bruce E. Eaton
| Unternehmen | Position | Beginn |
|---|---|---|
| North Carolina State University | Corporate Officer/Principal | 01.01.2000 |
Colorado BioScience Association
 Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Director/Board Member | - |
Ehemalige bekannte Positionen von Bruce E. Eaton
| Unternehmen | Position | Ende |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 02.01.2024 |
| i2 Pharmaceuticals, Inc. | Chief Executive Officer | 01.01.2018 |
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Chief Operating Officer | 01.10.2012 |
| Invenux, Inc. | President | 01.01.2002 |
| Washington State University | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Bruce E. Eaton
| University of California, Berkeley | Doctorate Degree |
| University of Oregon | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EDITAS MEDICINE, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
NeXstar Pharmaceuticals, Inc.
 NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious diseases. The firm was located in Boulder, CO. | Health Technology |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Health Technology |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Commercial Services |
| Invenux, Inc. | |
| i2 Pharmaceuticals, Inc. |
